In 2023, the import volume of Penicillins or Streptomycins in dosage forms to the US stood at approximately 9.2 million kilograms. From the provided forecasts, there is a steady increase in import volume from 2024 to 2028, with volumes rising from 9.31 to 9.72 million kilograms. Year-on-year growth is consistent at around 1.2%, indicating a stable market demand for these antibiotics.

Future trends to watch for include:

Potential regulatory changes impacting the import and use of antibiotics in terms of safety and resistance management.
Shift in global supply chain dynamics, which could affect pricing and availability.
Emergence of alternative treatments affecting the demand for traditional antibiotics.